| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 38 |
| 1 | INFLIXIMAB | 21 |
| 2 | PREDNISOLONE | 21 |
| 3 | PREDNISOLONE ORAL | 21 |
| 4 | PREDNISOLONE ORAL SOLUTION | 21 |
| 5 | NIVOLUMAB | 16 |
| 6 | ADALIMUMAB-AATY | 12 |
| 7 | ADALIMUMAB-ADAZ | 12 |
| 8 | ADALIMUMAB-FKJP | 12 |
| 9 | ALEMTUZUMAB | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PENPULIMAB | 1 | 0.0102 |
| 1 | PIOGLITAZONE HYDROCHLORIDE | 3 | 0.0024 |
| 2 | MEXILETINE HYDROCHLORIDE | 1 | 0.0024 |
| 3 | MIGLITOL | 1 | 0.0010 |
| 4 | ACETAMINOPHEN AND DIPHENHYDRAMINE HCL | 3 | 0.0009 |
| 5 | OLOPATADINE HYDROCHLORIDE OPHTHALMIC | 3 | 0.0007 |
| 6 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 2 | 0.0007 |
| 7 | ACETAMINOPHEN, DEXTROMETHORPHAN HBR | 3 | 0.0007 |
| 8 | POTASSIUM IODIDE | 1 | 0.0007 |
| 9 | SENNOSIDES A AND B | 1 | 0.0006 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 1 | CD19-directed Cytolytic Antibody [EPC] | 2 | 0.0023 |
| 2 | CD52-directed Cytolytic Antibody [EPC] | 11 | 0.0006 |
| 3 | Gonadotropin [EPC] | 1 | 0.0005 |
| 4 | Actinomycin [EPC] | 1 | 0.0005 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 36 | 0.0004 |
| 6 | Interleukin-17A Antagonist [EPC] | 11 | 0.0003 |
| 7 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |
| 8 | Ergot Derivative [EPC] | 1 | 0.0002 |
| 9 | CTLA-4-directed Blocking Antibody [EPC] | 9 | 0.0002 |